Incyte's vision is to become a leading drug discovery and development company by building a proprietary product pipeline of novel small molecule drugs. We have an experienced management and discovery team. Our assets, experience and prior success in bringing important new drugs to market put us in a strong position to make a difference in healthcare, improve the lives of patients and build significant sustainable value for our shareholders.
We have assembled a competitive and talented drug discovery and development team, which has extensive experience in a number of therapeutic areas. We have active internal drug discovery programs focused on the identification of novel small molecule drugs for oncology, inflammation, HIV and diabetes.
Jingang Li, Ph.D.
In this interview, AZoNano discusses the development of a novel solid-state optical nanomotor, which is driven by light.
Professor Jacek Jasienak
In this interview, we discuss a nanoparticle ink used to produce low-cost printable perovskite solar cells, helping to catalyze the technology transition toward commercial viable perovskite-based devices.
Ping Wang, Ph.D.
We speak with researchers behind the latest advancement in graphene hBN research that could boost the development of next-generation electronic and quantum devices.
Inoveno’s PE-550 is a best-selling electrospinning/spraying machine that can be used for the continuous production of nanofibers.
The Filmetrics R54 advanced sheet resistance mapping tool for semiconductor and compound semiconductor wafers.
The Filmetrics F40 turns your benchtop microscope into an instrument for measuring thickness and refractive index.